Provided by Tiger Fintech (Singapore) Pte. Ltd.

Repligen

120.11
+1.261.06%
Post-market: 120.110.00000.00%16:54 EDT
Volume:854.50K
Turnover:101.46M
Market Cap:6.75B
PE:-286.72
High:120.28
Open:119.00
Low:115.86
Close:118.85
Loading ...

Repligen Corporation Releases 2024 Sustainability Report

Reuters
·
27 May

Repligen Director Anthony Hunt Reports Disposal of Common Shares

Reuters
·
17 May

Repligen Corporation Conducted Annual Shareholder Meeting

Reuters
·
16 May

Repligen Price Target Maintained With a $180.00/Share by HC Wainwright & Co.

Dow Jones
·
05 May

QGEN or RGEN: Which Is the Better Value Stock Right Now?

Zacks
·
02 May

Repligen Corp. (RGEN) Slid On Uncertainty Related To U.S. Federal Government Spending On Healthcare

Insider Monkey
·
02 May

Jim Cramer on Regeneron Pharmaceuticals, Inc. (REGN): ‘Arguably The Most Innovative Biopharma Company I’ve Seen In The Last Two Decades’

Insider Monkey
·
02 May

Jim Cramer on Repligen Corporation (RGEN): ‘I’m Not Quite Ready to Stick My Neck Out on This One’

Insider Monkey
·
02 May

Repligen's Q1 Earnings Beat Estimates, Revenues Surge Y/Y

Zacks
·
30 Apr

RBC Lowers Price Target on Repligen to $189 From $202, Keeps Outperform Rating

MT Newswires Live
·
30 Apr

Repligen Corp : Leerink Partners Raises Target Price to $200 From $180

THOMSON REUTERS
·
30 Apr

Repligen Corp (RGEN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

GuruFocus.com
·
30 Apr

Q1 2025 Repligen Corp Earnings Call

Thomson Reuters StreetEvents
·
30 Apr

Repligen’s Earnings Call Highlights Robust Growth and Strategic Moves

TIPRANKS
·
30 Apr

Repligen Is Maintained at Overweight by JP Morgan

Dow Jones
·
30 Apr

Wolfe Research Upgrades Repligen to Outperform From Peerperform

MT Newswires Live
·
30 Apr

Repligen Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
29 Apr

Analysts Offer Insights on Healthcare Companies: Delcath Systems (DCTH), Repligen (RGEN) and CareDx (CDNA)

TIPRANKS
·
29 Apr

Repligen (RGEN) Tops Q1 Earnings and Revenue Estimates

Zacks
·
29 Apr

Repligen Q1 Adj. EPS $0.39 Beats $0.35 Estimate, Sales $169.17M Beat $163.83M Estimate

Benzinga
·
29 Apr